Published in Soc Work Public Health on July 01, 2016
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
In search of how people change. Applications to addictive behaviors. Am Psychol (1992) 28.48
Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry (2007) 8.21
The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry (1996) 4.93
A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis (1992) 4.64
Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry (1997) 3.67
Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician (2008) 2.90
Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med (2011) 2.70
Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse (1990) 2.69
Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med (2007) 1.84
Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat (2006) 1.70
Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend (2004) 1.60
Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010. MMWR Morb Mortal Wkly Rep (2012) 1.45
Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv (2014) 1.07
Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv (2014) 1.01
A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals. Int J Nurs Stud (2011) 0.98
Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Addiction (2007) 0.97
Opioid dependence treatment and guidelines. J Manag Care Pharm (2010) 0.96
Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity. J Opioid Manag (2010) 0.95
Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Mol Neurobiol (2011) 0.86